164 related articles for article (PubMed ID: 34652284)
21. [The role of low-dose computed tomography in lung cancer screening].
Ágh T; Szilberhorn L; Csanádi M; Széles G; Vokó Z; Ádám G; Kallai Á
Orv Hetil; 2022 Sep; 163(37):1464-1471. PubMed ID: 36088623
[TBL] [Abstract][Full Text] [Related]
22. Results of the national lung cancer screening trial: where are we now?
Chudgar NP; Bucciarelli PR; Jeffries EM; Rizk NP; Park BJ; Adusumilli PS; Jones DR
Thorac Surg Clin; 2015 May; 25(2):145-53. PubMed ID: 25901558
[TBL] [Abstract][Full Text] [Related]
23. Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial.
Pastorino U; Boeri M; Sestini S; Sabia F; Milanese G; Silva M; Suatoni P; Verri C; Cantarutti A; Sverzellati N; Corrao G; Marchianò A; Sozzi G
Ann Oncol; 2022 Apr; 33(4):395-405. PubMed ID: 35091076
[TBL] [Abstract][Full Text] [Related]
24. Characteristics and Outcomes of Lung Cancers Detected on Low-Dose Lung Cancer Screening CT.
Zhang EW; Shepard JO; Kuo A; Chintanapakdee W; Keane F; Gainor JF; Mino-Kenudson M; Lanuti M; Lennes IT; Digumarthy SR
Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1472-1479. PubMed ID: 34108138
[TBL] [Abstract][Full Text] [Related]
25. Evaluating the impact of varied compliance to lung cancer screening recommendations using a microsimulation model.
Han SS; Erdogan SA; Toumazis I; Leung A; Plevritis SK
Cancer Causes Control; 2017 Sep; 28(9):947-958. PubMed ID: 28702814
[TBL] [Abstract][Full Text] [Related]
26. Low-dose CT for lung cancer screening: opportunities and challenges.
Shen H
Front Med; 2018 Feb; 12(1):116-121. PubMed ID: 29218678
[TBL] [Abstract][Full Text] [Related]
27. Exploring the Impact of Lung Cancer Screening on Lung Cancer Mortality of Smokers With Obstructive Lung Disease: Analysis of the NLST-ACRIN Cohort.
de-Torres JP; Wisnivesky JP; Bastarrika G; Wilson DO; Celli BR; Zulueta JJ
Arch Bronconeumol (Engl Ed); 2021 Jan; 57(1):36-41. PubMed ID: 32409195
[TBL] [Abstract][Full Text] [Related]
28. Lung Cancer Screening by Low-Dose Computed Tomography - Part 1: Expected Benefits, Possible Harms, and Criteria for Eligibility and Population Targeting.
Kaaks R; Delorme S
Rofo; 2021 May; 193(5):527-536. PubMed ID: 33212540
[TBL] [Abstract][Full Text] [Related]
29. European and North American lung cancer screening experience and implications for pulmonary nodule management.
Nair A; Hansell DM
Eur Radiol; 2011 Dec; 21(12):2445-54. PubMed ID: 21830100
[TBL] [Abstract][Full Text] [Related]
30. Lung Cancer Screening Initiative in Slovakia: Guidelines of screening implementation.
Juskanic D; Sandor F; Denkova L; Juhos P; Janik M; Hontzas J; Mistinova JP; Senitko M; Ondrusova M
Bratisl Lek Listy; 2023; 124(2):109-115. PubMed ID: 36598297
[TBL] [Abstract][Full Text] [Related]
31. Systematic review of the cost-effectiveness of screening for lung cancer with low dose computed tomography.
Grover H; King W; Bhattarai N; Moloney E; Sharp L; Fuller L
Lung Cancer; 2022 Aug; 170():20-33. PubMed ID: 35700629
[TBL] [Abstract][Full Text] [Related]
32. Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial.
Aberle DR; Abtin F; Brown K
J Clin Oncol; 2013 Mar; 31(8):1002-8. PubMed ID: 23401434
[TBL] [Abstract][Full Text] [Related]
33. What is the Optimum Screening Strategy for the Early Detection of Lung Cancer.
Baldwin DR; Callister ME
Clin Oncol (R Coll Radiol); 2016 Nov; 28(11):672-681. PubMed ID: 27544425
[TBL] [Abstract][Full Text] [Related]
34. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
Field JK; Duffy SW; Baldwin DR; Brain KE; Devaraj A; Eisen T; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rintoul RC; Screaton N; Wald NJ; Weller D; Whynes DK; Williamson PR; Yadegarfar G; Hansell DM
Health Technol Assess; 2016 May; 20(40):1-146. PubMed ID: 27224642
[TBL] [Abstract][Full Text] [Related]
35. Current estimate of costs of lung cancer screening in the United States.
Mauchley DC; Mitchell JD
Thorac Surg Clin; 2015 May; 25(2):205-15. PubMed ID: 25901564
[TBL] [Abstract][Full Text] [Related]
36. Low-dose computed tomography screening for lung cancer: results of the first screening round.
Horeweg N; Nackaerts K; Oudkerk M; de Koning HJ
J Comp Eff Res; 2013 Sep; 2(5):433-6. PubMed ID: 24236740
[TBL] [Abstract][Full Text] [Related]
37. Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening.
Pastorino U; Sverzellati N; Sestini S; Silva M; Sabia F; Boeri M; Cantarutti A; Sozzi G; Corrao G; Marchianò A
Eur J Cancer; 2019 Sep; 118():142-148. PubMed ID: 31336289
[TBL] [Abstract][Full Text] [Related]
38. New evidence supporting lung cancer screening with low dose CT & surgical implications.
Dezube AR; Jaklitsch MT
Eur J Surg Oncol; 2020 Jun; 46(6):982-990. PubMed ID: 32113886
[TBL] [Abstract][Full Text] [Related]
39. An Update on the European Lung Cancer Screening Trials and Comparison of Lung Cancer Screening Recommendations in Europe.
Han D; Heuvelmans MA; Vliegenthart R; Rook M; Dorrius MD; Oudkerk M
J Thorac Imaging; 2019 Jan; 34(1):65-71. PubMed ID: 30325795
[TBL] [Abstract][Full Text] [Related]
40. Attitudes and Beliefs of Primary Care Providers in New Mexico About Lung Cancer Screening Using Low-Dose Computed Tomography.
Hoffman RM; Sussman AL; Getrich CM; Rhyne RL; Crowell RE; Taylor KL; Reifler EJ; Wescott PH; Murrietta AM; Saeed AI; Mishra SI
Prev Chronic Dis; 2015 Jul; 12():E108. PubMed ID: 26160294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
